This content is machine translated Anticoagulation from the perspective of internal medicine Foundations for an individualized “Choosing wisely”. DOAK are at least equal to standard therapy with VKA in non-valvular VCF and venous thromboembolism in terms of safety and efficacy. The intracranial bleeding risk is halved. Consequently, they…
View Post 4 min This content is machine translated Helicobacter pylori Eradication for the prevention of gastric cancer? At ASCO-GI in San Francisco, David Graham, MD, of Baylor College of Medicine, gave a presentation on the relationship between Helicobacter pylori and gastric cancer, emphasizing the importance of preventive…
View Post 6 min This content is machine translated ASH Congress in New Orleans What were the highlights? At the end of 2013, the 55th annual congress of the “American Society of Hematology” took place. Over 22,000 participants came to New Orleans, or “The Big Easy” as the…
View Post 4 min This content is machine translated Non-Hodgkin's Lymphoma Bortezomib in previously untreated multiple myeloma. A subanalysis of the VISTA trial was presented at the ASH Congress in New Orleans, showing that a higher cumulative dose of bortezomib resulted in a better outcome in patients…
View Post 3 min This content is machine translated Tumor patients A significantly increased risk of severe pulmonary embolism At the 24th Physicians’ Continuing Education Course in Clinical Oncology in St. Gallen was about the risk for venous thrombosis and pulmonary embolism in patients with malignant tumors. Not only…
View Post 4 min This content is machine translated Hepatocellular carcinoma What comes after sorafenib? At the ASCO-GI in San Francisco, hepatocellular carcinoma was one of the focal points. How can therapy be optimized and what are the options for patients who are progressive during…
View Post 8 min This content is machine translated ALPPS A promising innovation in liver surgery ALPPS, a new two-step hepatectomy, proved to be a good alternative to the classical methods of portal vein embolization and portal vein ligation in several small studies. The results show…
View Post 6 min This content is machine translated Progressive multiple sclerosis The next challenge is already waiting For the 16th time, the traditional State-of-the-Art Symposium of the Swiss Multiple Sclerosis Society took place in Lucerne in January 2014. This time, the presentations by national and international MS…
View Post 3 min This content is machine translated CLL11 study Combination of chlorambucil and CD20 antibody the new standard as early as 2014? In an interview with InFo ONCOLOGY & HEMATOLOGY, Michael Gregor, MD, of Lucerne Cantonal Hospital, talks about the CLL11 trial. It addresses the study population, the most relevant results, and…
View Post 6 min This content is machine translated Acute therapy on the stroke unit Time is brain – Why brief quickly? The success of stroke treatment is largely dependent on the time that elapses between symptom onset and recanalization of the occluded vessel. For this purpose, it is important that symptoms…
View Post 2 min This content is machine translated Stroke Treatment In the right place at the right time: How important is the “time is brain” concept? Stroke represents the most common neurological emergency and is one of the leading causes of mortality and morbidity worldwide. In this context, 85% of all strokes are ischemic, and the…
